In diagnostic practice, while TFE3 immunohistochemistry demonstrates high sensitivity, its specificity is limited; therefore, detection of ASPSCR1-TFE3 fusion transcripts is regarded as the definitive diagnostic criterion for ASPS (9, 12). This evidence concerns the gene ASPSCR1 and alveolar soft part sarcoma.